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Abstract: The intake of sugar-sweetened beverages has been associated with an augmented preva-
lence of metabolic diseases, namely, obesity, type II diabetes, and metabolic syndrome. On the
other hand, nowadays, it is broadly accepted that foods and beverages rich in (poly)phenols could
contribute to reducing the incidence of these pathologies. In this sense, the objective of the work was
to revalue second quality citrus fruits for the development of new beverages, rich in anthocyanins and
flavanones (maqui berry and second qualities citrus-based), and evaluate the influence of alternative
sweeteners (sucralose, sucrose, or stevia), regarding the bioaccessibility and bioavailability of these
bioactive compounds in the frame of a chronic (longitudinal) intervention. To fulfill this objective,
a longitudinal study of the urinary excretion of anthocyanins and flavanones, after 2-months of
ingestion of the developed maqui-citrus beverage, by 138 volunteers (n = 46 per beverage) and the
analysis of the resulting phenolic metabolites by ultra-high performance liquid chromatography
coupled to mass spectrometry (UHPLC-ESI-QqQ-MS/MS) was carried out. As major results, the
bioavailable metabolites of caffeic acid (CA), catechol (CAT), 3,4-di-hydroxyphenylacetic acid (DH-
PAA), eriodictyol (E), homoeriodictyol (HE), hippuric acid (HA), naringenin (N), trans-ferulic acid
(TFA), 2,4,6-tri-hydroxybenzaldehyde (THBA), trans-isoferulic acid (TIFA), and vanillic acid (VA)
were detected. Accordingly, significantly different bioavailability was dependent on the sweetener
used, allowing proposing stevia and, to a lower extent, sucralose, as valuable alternatives to sucrose.
Keywords: dietary intervention; beverage; anthocyanins; flavanones; bioavailability; UHPLC-ESI-
QqQ-MS/MS
1. Introduction
The rising incidence of metabolic diseases, namely, obesity, metabolic syndrome,
or type II diabetes mellitus, is one of the main social challenges ahead now and in the
coming years [1]. These diseases are closely related to dietary habits, in general, and
particularly associated with the consumption of sugar-sweetened beverages [2]. Moreover,
the intake of this type of beverage has been associated with weight gain, hypertension, and
cardiovascular diseases that could threaten the sustainability of the health systems [3–5].
To minimize the consumption of sugar-sweetened beverages, global trends, based on
the use of alternative sweeteners towards healthy beverages, sources of dietary bioactive
compounds, are focusing the attention of the research activity [6], because of the effect of
replacing sugar with artificial sweeteners on the risk of developing chronic pathologies,
such as cardiovascular diseases or type II diabetes mellitus, among others [7].
In parallel to sugar replacement strategies, fruit beverages/juices, which are rich in
bioactive compounds with demonstrated health benefits, could therefore contribute to
preventing the incidence and severity of those pathologies referred above, associated with
sugar consumption [8]. Thereby, this fact has boosted the assessment of newly developed
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bioactive beverages based on fruits featured by a valuable content of (poly)phenols [9,10],
which consumption entails a bioavailability of (poly)phenols ranging between 5 and 10%.
However, it has to be noticed that these bioavailability ratios correspond to studies focused
on non-metabolized compounds, while the values rise to 60–70% when considering also
the formation of phase II metabolites. Anyway, the efficiency of intestinal absorption of
bioactive (poly)phenols is mostly conditioned by the physicochemical properties of the
diverse food/beverage matrices that influences the bioaccessibility of the compounds of
interest, as well as the interindividual variability [11]. Despite this controversy, upon
a study carried out by Ribas-Agusti et al. [12], positive interactions between sucrose
and phenolic compounds have been suggested, which would inform on the relevance of
sugar for establishing the actual (poly)phenols bioavailability. This fact has been partially
explored by Agulló et al. [13,14], who reported stevia and sucralose as valuable alternatives
to sucrose, in terms of bioavailability of phenolic compounds after an acute administration
of a (poly)phenol-rich beverage. In this regard, the long-term intervention study described
in the present work provides helpful information to augment the knowledge about the
effect of stevia and sucralose on human health after long-term ingestion.
Maqui berry (Aristotelia chilensis (Mol.) Stuntz) is a purple blackberry from Chile
and Argentina rich in anthocyanins (delphinidin and cyanidin derivatives) that has been
broadly selected to develop healthy beverages, because of the biological attributions of
its (poly)phenolic fraction (high antioxidant capacity, cardio-protection, and inhibition of
adipogenesis and diabetes symptoms) [9]. On the other hand, citrus fruits are featured
by an outstanding flavanone content, with naringenin, eriocitrin, and hesperidin being
the most representative flavanones in these fruits. This composition has prompted the
selection of, mainly lemon plus other, citrus fruits to design and develop new bioactive
beverages [8,13–15]. Indeed, the phenolic composition described for citrus fruits has been
associated with health benefits against cardiovascular disease, cancer, type II diabetes
mellitus, and obesity [15,16]. The citrus, mainly lemon fruit, production entails a high
proportion of by-products represented by second quality fruits featured by a lower appear-
ance quality that cannot be marketed for fresh consumption, being required to envisage
additional applications that would contribute to the sustainability of its production in the
Mediterranean Basin [15,17]. In this regard, the use of the second quality citrus fruits in the
development of new potentially bioactive beverages could be a valuable approach to take
advantage of a second quality product that does not allow their commercialization for fresh
consumption. However, the identification of valorization alternative as a source of dietary
bioactive (poly)phenols provides an especially appropriate use, allowing obtaining new
added-value beverages, as its processed juice is not very appreciated, due to its high acidity.
Taking into account that background and following previous researches [13,14], the
present work deals with the relationship between sweeteners and bioavailability of phenolic
compounds, especially flavanones and anthocyanins, on healthy overweighed humans,
after a chronic intake of maqui-citrus drinks with different sweeteners: sucrose (natural high
caloric), stevia (natural non-caloric), and sucralose (artificial non-caloric). This approach
would allow us a new advance, monitoring the possible accumulative effect of these
(poly)phenols, as well as valorizing second qualities citrus, not allowed for fresh for
fresh consumption.
2. Materials and Methods
2.1. Chemicals and Reagents
Cyanidin (Cy) 3-O-glucoside, delphinidin (Dp) 3-O-glucoside, eriodictyol (E), homoe-
riodictyol (HE), naringenin, and hesperetin were purchased from TransMIT (Geiben, Ger-
many). Hesperidin, eriocitrin, and naringenin were obtained from Merck (Darmstadt, Ger-
many). Caffeic (CA; also known as 3,4-di-hydroxycinnamic acid), gallic (GA; also known
as 3,4,5-tri-hydroxybenzoic acid), 3,4-di-hydroxyphenylacetic (DHPAA), hippuric (HA),
trans-ferulic (TFA; also known as 4-hydroxy-3-methoxycinnamic acid), trans-isoferulic
(TIFA; also known as 3-hydroxy-4-methoxycinnamic acid), and vanillic (VA; also known
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as 4-hydroxy-3-methoxybenzoic acid) acids, 2,4,6-tri-hydroxybenzaldehyde (THBA), and
catechol (CAT; also known as benzene-1,2-diol) were obtained from Sigma-Aldrich (Stein-
heim, Germany). Formic acid and acetonitrile of analytical grade were obtained from
Fisher-Scientific (Loughborough, UK). All solutions were prepared with ultrapure deion-
ized water from a Milli-Q Advantage A10 ultrapure water purification system (Millipore,
Burlington, MA, USA).
2.2. Beverages Preparation and Characterization of the Phenolic Content
Maqui New Life S.A. (Santiago, Chile), and Cítricos de Murcia S.L. (Ceutí, Spain) and
AMC Grupo Alimentación Fresco y Zumos S.A. (Espinardo, Spain) provided fresh dry or-
ganic maqui powder and the citrus juices, respectively. Sucrose, Stevia, and sucralose were
provided by AB Azucarera Iberia S.L. (Madrid, Spain), AgriStevia S.L. (Molina de Segura,
Spain), and Zukan (Murcia, Spain), respectively.
Maqui-citrus beverages’ (maqui plus mainly second quality lemon together with
other citrus juices) performance was according to the previous description in the bibliog-
raphy [18]. Briefly, maqui powder was mixed with juices elaborated from second quality
citrus fruits (lemon juice mixed with other citrus in a certain proportion, in order to re-
duce acidity and obtain a more acceptable beverage) to obtain the base drink. Afterward,
sweeteners were added in different proportions, stevia 4 mg per 100 mL and sucrose
7.5 g per 100 mL, to obtain similar acceptable sweetness in all beverages. Each different
sweetener beverage (400 L) was pasteurized according to common industrial standards
(85 ◦C for 15 s) for citrus drinks and pH at the Universidad Miguel Hernández (Orihuela,
Alicante, Spain, under the supervision of Dr Martí) and bottled (330 mL volume bottles).
This was repeated every 15 days, as the drinks were provided in lots of 15 bottles, for
their intake in the following 15 days, with instructions for preserving them in the fridge.
In this way, the freshness of the ready-to-drink beverages was preserved. The type of
sweetener was unknown for volunteers, researchers (who provided the beverages, and
collected/processed the samples), as well as for researchers that developed the statistical
analyses. The phenolic composition of the beverages developed was studied following the
methodology previously described [18,19]. The proximate composition of the juices was
also determined (Table S1). Moreover, quality and safety tests were performed, as well as
shelf-life tests, which confirmed that the beverages were innocuous from the toxicological
and microbiological point of view, while the nutritional and phytochemical composition
remained intact [18].
2.3. Experimental Design
A double-blind, randomized, longitudinal, crossover clinical study was performed in
overweight individuals (n = 138), by the Catholic University of Murcia (UCAM, Murcia,
Spain), under the supervision of Dr. Villaño. The study was conducted under the principles
of the Declaration of Helsinki, and the protocol was approved by the Official Ethical
Committee of Clinical Studies (CEIC) of University Hospital “Morales Meseguer” (Murcia,
Spain) and registered at ClinicalTrials.gov (NCT04016337). Overweight volunteers (BMI:
~28) were provided with written information about the study and all of them signed the
informed consent. The criteria for volunteers’ selection to participate in the study were as
followed in previous studies [13,14]. The intervention study consisted of the daily ingestion
of the maqui-citrus beverage (330 mL), over 60 days. Urine samples were collected at the
initial (day 0) and final days of intervention (day 60) and were stored at −80 ◦C until
analyses that were performed once the intervention period was finished and in the same
batch to minimize analytical variations.
2.4. Urine Samples Collection, Processing, and Analysis by UHPLC-ESI-QqQ-MS/MS
Urine samples were processed following the method previously described [13,14].
The identification and quantification of phenolic metabolites were performed by applying
the method previously reported [13,14].
Nutrients 2021, 13, 312 4 of 11
2.5. Statistical Analysis
Quantitative data are presented as mean ± SD of 46 volunteers. Specific differences
between basal and final concentrations were examined by a paired t-test based on their
normal distribution. The data were processed using the SPSS 25.0 software package
(SPSS Inc., Chicago, IL, USA) and the level of significance was set at p < 0.05.
3. Results
3.1. (Poly)phenolic Content of Beverages
The assessment of the beverages performed using three different sweeteners (stevia,
sucrose, and sucralose) on their (poly)phenolic quantitative profile allowed identifying their
content of individual flavanones and anthocyanins. In this regard, it was observed the
presence, in the drinks, of four flavanones, which were found in the following decreasing
concentration order, hesperidin (hesperetin 7-O-rutinoside) > eriocitrin (eriodictyol 7-O-
rutinoside) > narirutin (naringenin 7-O-rutinoside) > O-tri-glycosyl-naringenin (Table 1).
Table 1. Flavanone composition (mg/100mL) of the maqui-citrus beverages.
Flavanone Stevia Sucralose Sucrose p-Value
O-triglycosyl-N Z 0.18 ± 0.01 0.20 ± 0.01 0.18 ± 0.01 >0.05 N.s. Y
E 7-O-rutinoside 1.95 ± 0.01 1.85 ± 0.01 1.92 ± 0.01 >0.05 N.s. Y
N 7-O-rutinoside 1.73 ± 0.01 1.74 ± 0.01 1.71 ± 0.01 >0.05 N.s. Y
H 7-O-rutinoside 9.09 ± 0.01 9.18 ± 0.01 9.06 ± 0.01 >0.05 N.s. Y
TOTAL 12.95 ± 0.10 12.97 ± 0.13 12.87 ± 0.13 >0.05 N.s. Y
Z N, naringenin; E, eriodictyol; H, hesperetin. Y N.s., not significant.
On the other hand, regarding anthocyanins, it was found Dp 3,5-O-di-glc > Dp 3-
O-sam-5-O-glc ≈ Dp 3-O-glc > co-eluting Cy 3-O-sam-5-O-glc and Cy 3,5-O-di-glc > Dp
3-O-sam > Cy 3-O-glc > Cy 3-O-sam (Table 2). When comparing the quantitative profile of
the separate drinks, no statistically significant differences (p > 0.05) were observed between
the concentration of the flavanones and anthocyanins identified in the separate maqui-
citrus drinks, as a consequence of the sweetener applied, concerning both individual and
total flavanones and anthocyanins (Tables 1 and 2).
Table 2. Anthocyanin composition (mg/100mL) of the maqui-citrus beverages.
Anthocyanin Stevia Sucralose Sucrose p-Value
Dp 3-O-sam-5-O-glc Z 4.48 ± 0.01 4.48 ± 0.01 4.49 ± 0.01 >0.05 N.s. Y
Dp 3,5-O-diglc 5.13 ± 0.01 5.07 ± 0.01 5.09 ± 0.01 >0.05 N.s. Y
Cy 3-O-sam-5-O-glc +
Cy 3,5-O-di-glc 2.07 ± 0.01 2.11 ± 0.01 2.09 ± 0.01 >0.05
N.s. Y
Dp 3-O-sam 1.53 ± 0.01 1.51 ± 0.01 1.49 ± 0.01 >0.05 N.s. Y
Dp 3-O-glc 4.46 ± 0.01 4.48 ± 0.01 4.47 ± 0.01 >0.05 N.s. Y
Cy 3-O-sam 0.53 ± 0.01 0.51 ± 0.01 0.50 ± 0.01 >0.05 N.s. Y
Cy 3-O-glc 0.81 ± 0.01 0.81 ± 0.01 0.80 ± 0.01 >0.05 N.s. Y
TOTAL 19.01 ± 0.22 18.97 ± 0.20 18.93 ± 0.23 >0.05 N.s. Y
Z Cy, cyanidin; Dp, delphinidin; Glc, glucoside; Sam, sambubioside. Y N.s., not significant.
This (poly)phenolic content is, to some extent, in agreement with the drinks developed
by Gironés et al., being the differences found probably due to the diverse formulations
of the beverages used in both studies. In this regard, the beverages described by Girones
et al. were characterized by the antioxidant capacity, as well as lipase and α-glucuronidase
inhibitory activity, demonstrating an important role in the prevention of obesity and type
II diabetes mellitus, among other metabolic disorders [9,19].
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3.2. Characterization of the Urine Profile of Flavanones and Anthocyanins Ingested by
Maqui-Citrus Beverages
The assessment of the urine profile of flavanones and anthocyanins present in the
maqui-citrus beverages, which were absorbed at the intestinal level, metabolized, and ex-
creted by the urine, was done to identify differences tentatively attributable to the sweetener
employed (stevia, sucralose, and sucrose). Thereby, it was applied a targeted metabolomic
approach for the identification of the 36 (poly)phenolic urine metabolites described in pre-
vious acute intervention studies (Complementary data Table S2) [13,14]. Specifically, from
the range of the target (poly)phenolic derivatives monitored, the compounds identified,
in the present chronic intervention study, were caffeic acid (CA), CA glucuronide, CA
sulfate, CA glucuronide-sulfate, catechol (CAT) sulfate, 3,4-di-hydroxyphenylacetic acid
(DHPAA), DHPAA glucuronide, DHPAA di-glucuronide, DHPAA glucuronide-sulfate,
DHPAA di-sulfate, eriodictyol (E), E glucuronide, E sulfate, E di-sulfate, homoeriodictyol
(HE), HE glucuronide, HE di-glucuronide, HE sulfate, hippuric acid (HA), HA sulfate,
naringenin (N), N glucuronide, N di-glucuronide, N sulfate, N glucuronide-sulfate, trans-
ferulic acid (TFA) glucuronide, TFA di-glucuronide, TFA sulfate, TFA di-sulfate, 2,4,6-tri-
hydroxybenzaldehyde (THBA) glucuronide, trans-isoferulic acid (TIFA) sulfate, vanillic
acid (VA), VA di-glucuronide, VA glucuronide-sulfate, and VA di-sulfate.
Interestingly, regarding the anthocyanins and hesperidin, their aglycones were not de-
tected. Regarding anthocyanins, this fact could be attributed to the degradation under the
physicochemical conditions featuring gastrointestinal digestion and/or their metabolism
after absorption as a result of phase II metabolic reactions in the intestine epithelium
and hepatocytes, forming glucuronide-, sulfate-, or methyl-derivatives in the proximal
gastrointestinal tract [20]. Similarly, the lack of successful identification of hesperetin
derivatives could be due to the participation of similar metabolic routes in the metabolism
of flavanones. Besides, some phenolic metabolites referred to above were found in the
urine of a reduced number of volunteers, specifically catechol sulfate, eriodictyol (E) di-
sulfate, homoeriodictyol (HE) and its metabolites (HE di-glucuronide and HE sulfate),
naringenin (N) glucuronide-sulfate, trans-ferulic acid (TFA) di-glucuronide, and 2,4,6-
tri-hydroxybenzaldehyde (THBA) glucuronide. Indeed, these compounds were found
in quantifiable concentrations in the urine of a limited number of volunteers that turns
them into no representative. This fact may be due to interindividual variations regard-
ing metabolic traits, also responsible, in the frame of the assessments described in the
present work, for the dispersion featuring the concentrations of the metabolites identified
in vivo [21]. On the other hand, caffeic acid (CA) and its metabolites (CA glucuronide, CA
sulfate, and CA glucuronide-sulfate), 3,4-di-hydroxyphenylacetic acid (DHPAA) and its
metabolites (DHPAA glucuronide, DHPAA di-glucuronide, DHPAA glucuronide-sulfate,
and DHPAA di-sulfate), eriodictyol (E) and its metabolites (E glucuronide and E sulfate),
homoeriodictyol (HE) glucuronide, hippuric acid (HA), and HA sulfate, naringenin (N) and
its metabolites (N glucuronide, N di-glucuronide, and N sulfate), trans-ferulic acid (TFA)
metabolites (TFA glucuronide, TFA sulfate, and TFA di-sulfate), trans-isoferulic acid (TIFA)
sulfate, and vanillic acid (VA) and its metabolites (VA di-glucuronide, VA glucuronide-
sulfate, and VA di-sulfate) were identified and quantified in the urine of all volunteers.
Nevertheless, hippuric acid (HA) was not taken into consideration because of its high
basal levels found as a result of its endogenous production, as well as the widespread
occurrence of this compound in a broad diversity of dietary sources, which did not allow
the quantification of the amount obtained from the metabolism of the (poly)phenols of the
maqui-citrus beverages [22].
3.3. Urine Concentration of Flavanone and Anthocyanin Metabolites after Chronic Ingestion of
Maqui-Citrus Beverages
The quantification of the metabolites excreted in the urine was developed on basal
urine (before the beginning of the dietary intervention) and the urine excreted after 60 days
of daily ingestion of 330 mL of maqui-citrus beverage (Figure 1). The data retrieved
evidenced that, although 27 metabolites were identified and quantified in the urine of all
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volunteers, exhibiting a rising trend relative to the concentration recorded in the basal
urine. The differences found were statistically significant only for the 15 metabolites
showed in Figure 1. Thus, although the dietary intervention set-up allowed increasing the
bioavailability of the bioactive compounds present in the maqui-citrus drik, the absence of
significant differences for some of them would be attributable to interindividual variations
of the metabolic traits that give rise to the dispersion of data on the quantitative profile
of urine metabolites. Indeed, this fact is a major constraint associated with the dietary
intervention studies that would difficult the identification of the actual differences between
basal and final urine concentration for the metabolites of interest.
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urine of healthy volunteers after daily ingestion of 330 mL of maqui-citrus drinks developed using as sweeteners stevia
(red ∆), sucralose (blue O), and sucrose (black ).
3.3.1. Caffeic Acid Derivatives
Regarding the metabolites consistently excreted by most volunteers, caffeic acid (CA)
is a natural phenolic compound and a common degradation product of both flavanones
and anthocyanins [22]. The bioavailability of CA involves a range of derivatives, namely,
unesterified caffeic acid (CA), CA glucuronide, and CA sulfate, that, in the present work,
showed a significant increase (p < 0.05) after 60 days consumption of the citrus-maqui-berry
beverages, closely dependent on the sweetener applied (Figure 1). When analyzing the
different concentrations obtained depending on the beverage ingested, the highest amount
of the separate CA derivatives was achieved as a result of the intake of drinks developed
sing sucrose as a sweetener (0.03, 0.24, and 0.39 µg/mg of reatinine f r un sterified CA,
CA glucuronide, and CA sulfat , resp ctively). However, regarding unesterified caffeic
acid (CA), beverages don us ng sucrose nd stevia showed the high t percentage incr ase
relative to the basal levels (41% and 39%, respe tiv ly). Concerning the glucuro ide a d
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sulfate derivatives of caffeic acid (CA), the beverage including sucralose as a sweetener
provided a 34% and 55% higher increase, respectively, than stevia- and sucrose-based
drinks, on average (Figure 1).
Concerning these metabolites, when applying a paired t-test to identify the statistically
significant augments attained depending on the sweetener used in the development of
the beverages, it was observed that the urine excretion of unesterified CA augmented
significantly after the ingestion of stevia- and sucrose-based beverage (p < 0.01), as well
as, to a lower extent, sucralose-based beverages (p < 0.05). Besides, for CA glucuronide,
a significant augment (p < 0.001) was observed independently of the sweetener used.
Regarding CA sulfate, sucralose-based drinks provided the most significant increase of the
urine concentration (p < 0.001), followed by stevia- and sucrose-based beverages, which
remained at a similar level (p < 0.05) (Figure 1). Furthermore, CA glucuronide-sulfate
was not detected in the basal urine, but after the ingestion of the newly developed drinks,
the highest values were reached due to the intake of the sucrose-sweetened beverage
(0.003 µg/mg of creatinine). With respect to the biological attributions of bioavailable CA
derivatives, to the present date, it has been reported several healthy properties, such as a
protective activity against type II diabetes mellitus and angiopathy, along with valuable
contributions to the regulation of gut microbiota [23,24]. In this regard, the augmented
bioavailability of such metabolites, as a result of this dietary intervention, would connect the
exploration of new sweeteners with a positive effect on health derived from the augmented
bioavailability of bioactive (poly)phenols, beyond the only reduction of the sugar intake
and its harmful metabolic effects.
3.3.2. 3,4-Di-Hydroxyphenylacetic Acid Derivatives
Regarding 3,4-di-hydroxyphenylacetic acid (DHPAA), this is a microbiota metabolite
of flavonoids, on which has been reported valuable biological properties and health benefits
that, according to the major outcomes described in the present work, would be enclosed
to the dietary intake of maqui-citrus beverages [25]. Indeed, DHPAA has been associated
with the prevention or delay of glucotoxicity, a key event in the pathogenesis of type II
diabetes mellitus, as well as with the protection against pancreatic β-cells dysfunction
developed in the frame of hypercholesterolemia [25,26]. This metabolite was found in non-
esterified and conjugated forms, being the diglucuronide derivative the only compound
exhibiting a significant augment of the urine concentration as a result of the beverages’
intake. The highest urine concentration of non-esterified DHPAA (0.38 µg/mg of creatinine)
and the highest augment (85%) corresponded to the ingestion of stevia-sweetened drinks.
On the other hand, regarding DHPAA diglucuronide, the highest urine concentration
matched with the consumption of beverages prepared using sucrose (0.02 µg/mg of
creatinine), as well as the highest percentage augment relative to the basal levels (72%).
When analyzing the statistical significance of the augments observed, these corresponded
to the consumption of stevia- and sucralose-based beverages (p < 0.001) and sucrose-based
drinks (p < 0.05) for non-esterified DHPAA, and to the daily ingestion of sucralose and
sucrose sweetened drinks (p < 0.05 and p < 0.01, respectively) for DHPAA di-glucuronide.
3.3.3. Eriodictyol, Homoeriodictyol, and Naringenin Derivatives
Eriodictyol (E) is a flavanone present in citrus fruits in a glycosylated form (bound to a
rutinoside (Table 1)) and characteristic of lemon. This flavanone was presented in urine non-
esterified, as well as bound to sulfate as a result of phase II reactions (E sulfate). Regarding
both of them, the highest urine concentration was achieved because of the consumption of
sucrose-sweetened beverages (0.01 and 0.09 µg/mg of creatinine, for non-esterified E and
E sulfate, respectively). Moreover, non-esterified E experienced a significant augment after
the consumption of the maqui-citrus beverages developed using sucrose and sucralose as
sweeteners (p < 0.001 and p < 0.01). However, the intake of stevia-based beverages showed
a significant augment of E sulfate (p < 0.001) (Figure 1).
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In the case of homoeriodictyol (HE) and naringenin (N) derivatives, HE glucuronide
and N glucuronide, respectively, were the only metabolites detected. Both increased the
urine concentration significantly after the intake of maqui-citrus drinks, independently of
the sweetener applied (p < 0.001), although the use of sucralose and stevia gave rise to the
highest augment for these metabolites. Besides, the sucralose-based beverage provided the
highest values for HE glucuronide (2.08 µg/mg of creatinine) and the sucrose-based drink
for N glucuronide (142.69 µg/mg of creatinine) (Figure 1).
As referred to before, the flavanones eriodictyol, homoeriodictyol, and naringenin
are the most representative (poly)phenols in citrus fruits. Furthermore, these phenolic
compounds have been noticed regarding the healthy properties in humans, namely anti-
cancer, antidiabetic, neuroprotective, anti-obesity, anti-inflammatory, cardioprotective, and
hepatoprotective, among others [27,28]. In this regard, Liu et al. [29] reported recently that
eriodictyol and naringenin can inhibit the formation of advanced glycation end products,
closely related to several pathologies like Alzheimer’s disease, neuropathy, retinopathy, or
nephropathy [30]. Again, these biological traits further support the modifications of the
chemical and phytochemical characteristics of fruit juices that could affect positively the
bioavailability of such molecules, and thus the biological effect that could be foreseen.
3.3.4. Trans-Ferulic Acid Derivatives
Concerning trans-ferulic acid (TFA), a phenolic acid formed enzymatically from caffeic
acid (CA) in enterocytes, the sulfate derivative was the only phase II metabolite, whose
urine concentration augmented significantly for all sweeteners (p < 0.01 for stevia- and
sucralose-based beverages, and p < 0.05 for sucrose-based beverage) [20]. However, al-
though sucralose was the sweetener providing the highest concentration (10.86 µg/mg
of creatinine), the intake of stevia-sweetened drinks yielded the highest bioavailability
in terms of percentage. This metabolite would be responsible, to some extent, for the
biological benefits expected from the consumption ofmaqui-citrus beverages, especially
because of its properties against metabolic syndrome [31,32]. Besides, the combination of
this phenolic compound with caffeic acid (CA) has been reported as a promising therapy
against multiple aspects of this syndrome, as well as against liver steatosis as recently
defined through an overweight mouse model [32].
3.3.5. Vanillic Acid Derivatives
Finally, vanillic acid (VA) also showed a significant increase of the urine concentration
according to the results retrieved from the paired sample t-test applied (p < 0.001 for
stevia-based drinks, p < 0.01 for sucralose-based beverage, and p < 0.05 for sucrose-based
beverage). Despite the ingestion of the sucrose-based beverages provided the highest
values of this metabolite in urine (24.16 µg/mg of creatinine), the intake of beverages
developed using stevia as a sweetener, duplicated the basal values, providing the highest
increase. This outcome is of special relevance, because of the association of this compound
to anti-cancer, anti-obesity, anti-inflammatory, and cardioprotective features [33–35].
Overall results referred to the bioavailability of flavanones and anthocyanins metabo-
lites after the intake of the beverages developed indicated that stevia was the most effi-
cient sweetener, in respect to the capacity of the maqui-citrus beverage to raise the basal
urine concentration for most metabolites (caffeic acid, 3,4-di-hydroxyphenylacetic acid,
eriodictyol sulfate, naringenin glucuronide, trans-ferulic acid sulfate, and vanillic acid),
followed by sucralose (caffeic acid glucuronide, caffeic acid sulfate, and homoeriodictyol
glucuronide), and sucrose (caffeic acid, 3,4-di-hydroxyphenylacetic acid di-glucuronide,
and eriodictyol). These results are in agreement with previous research of the own group,
suggesting stevia, a natural non-caloric sweetener, as a valuable alternative to sucrose to re-
duce sugar intake [13,14]. Furthermore, results showed an increase along the time for most
metabolites produced from the (poly)phenolic load of the beverages under consideration,
regardless of the significance of the augment and the sweetener employed. This suggests
an accumulative effect as a result of the chronic consumption of newly designed beverages.
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Besides, the healthy properties of the metabolites detected are of special interest due to the
biological properties described, which reinforce the protective attributions of the precursor
flavanones and anthocyanins against a range of pathophysiological situations.
Moreover, it is important to notice that no differences were observed between BMI at
the baseline and 60 days of ingesting maqui-citrus beverages for any of the experimental
groups included in the design of the study (mean 28 for all groups at day 0 and 60). These
results suggested that there are no differences between sucrose (natural high caloric), stevia
(natural non-caloric), and sucralose (artificial non-caloric) in terms of directly modifying the
basic nutritional or metabolic status of volunteers. Furthermore, it has to be mentioned that
the data from blood samples and from physic parameters (i.e., BMI) would be published
somewhere else.
4. Conclusions
The results described in the present work evidence a great diversity of metabolites,
including phase II derivatives, synthesized due to the metabolism of flavanones and antho-
cyanins present in maqui-citrus beverages, elaborated from maqui berry and second quality
citrus fruits. However, neither parental anthocyanin nor hesperidin aglycones were found.
Thus, the major outcomes retrieved suggest stevia as the sweetener that allows obtaining
a higher bioavailability for most metabolites of the (poly)phenols present in the newly
developed beverages as the basal urine concentrations of these metabolites raised signifi-
cantly after the ingestion of stevia-sweetened beverages. These metabolites represented all
the spectrum of phenolic compounds identified (caffeic acid, 3,4-di-hydroxyphenylacetic
acid, eriodictyol, naringenin, trans-ferulic acid, and vanillic acid, except homoeriodictyol)
after the beverage intake, regardless of the form (unesterified or phase II derivatives) in
which they are detected. Moreover, the beverage sweetened with stevia will group all
the healthy properties of the compounds commented above against diseases related to
sugar consumption. Concerning sucralose and sucrose, both sweeteners caused the highest
bioavailability of coincident metabolites, and thus the efficiency of these sweeteners can
be considered as equal. However, the urine concentration values augmented for most
derivatives after two months of dietary intervention, independently of the sweetener used,
suggesting these metabolites as persistent over time in the volunteers.
As referred above and according to the results retrieved, the use of second quality
lemon or other citrus fruits contributes to preventing the incidence and severity of metabolic
diseases. Therefore, their inclusion as an ingredient, source of bioactive (poly)phenols, and
metabolic derivatives in the newly designed beverages would provide an alternative use
for second quality fruits, allowing industries to minimize production losses, along with
taking advantage of the benefits for health associated to their (poly)phenolic profile.
Summarizing, when considering the differences in the bioactive compounds bioavail-
ability dependent on the sweetener used, this study suggests stevia and, to a lesser extent,
sucralose are valuable alternatives to sucrose, which is directly related to the incidence,
prevalence, and severity of type II diabetes mellitus, obesity, and cardiovascular diseases,
among other deleterious pathological conditions.
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